Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant Medical Countermeasures September 17, 2023 …
Latest Covid Variant Threatens to be Most Adept at Evading Immunity Biosurveillance August 25, 2023 …
Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy Industry News August 22, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
BD Gets FDA Clearance for Influenza, RSV, COVID-19 Respiratory Viral Panel Biodetection August 1, 2023 …
Intelligence Report Says Safety Training at Wuhan Lab Before the Pandemic Appears Routine Biosecurity July 7, 2023 …
Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19 Industry News July 6, 2023 …
Many Children Hospitalized with COVID-19 or MIS-C Have Lingering Complications Months Later Infectious Diseases August 12, 2022 …
Children Infected with a Mild Case of COVID-19 Can Still Develop Long COVID Symptoms Infectious Diseases August 10, 2022 …
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19 Public Health July 17, 2022 …
